Heparin Sodium 10 I.U./ml flushing solution for maintenance of patency of intravenous devices Irska - engleski - HPRA (Health Products Regulatory Authority)

heparin sodium 10 i.u./ml flushing solution for maintenance of patency of intravenous devices

pinewood laboratories ltd - heparin sodium - irrigation solution - 10 international unit(s)/millilitre - heparin group; heparin

Heparin sodium 25,000 I.U./ml Solution for injection or concentrate for solution for infusion, 0.2ml ampoules Irska - engleski - HPRA (Health Products Regulatory Authority)

heparin sodium 25,000 i.u./ml solution for injection or concentrate for solution for infusion, 0.2ml ampoules

pinewood laboratories ltd, - heparin sodium - solution for injection/infusion - 25,000 international unit(s)/millilitre - heparin group; heparin

Heparin sodium 25,000 I.U./ml Solution for injection or concentrate for solution for infusion, 5 ml vials Irska - engleski - HPRA (Health Products Regulatory Authority)

heparin sodium 25,000 i.u./ml solution for injection or concentrate for solution for infusion, 5 ml vials

pinewood laboratories ltd, - heparin sodium - solution injection or concentrate for solution infusion - 25000 international unit(s)/millilitre - heparin group; heparin

Heparin sodium 5,000 I.U./ml Solution for injection or concentrate for solution for infusion, 5 ml vials Irska - engleski - HPRA (Health Products Regulatory Authority)

heparin sodium 5,000 i.u./ml solution for injection or concentrate for solution for infusion, 5 ml vials

pinewood laboratories ltd - heparin sodium - solution for injection/infusion - 5000 international unit(s)/millilitre - heparin group; heparin

Heparin Sodium Injection USP 5000IU/5ml Kenija - engleski - Pharmacy and Poisons Board

heparin sodium injection usp 5000iu/5ml

heparin sodium injection usp 5000iu/5ml - injection - each ml contains: heparin sodium usp 1000 iu - heparin

HEPARIN SODIUM B.BRAUN 5000 IUML Izrael - engleski - Ministry of Health

heparin sodium b.braun 5000 iuml

lapidot medical import and marketing ltd - heparin sodium - solution for injection / infusion - heparin sodium 5000 iu - heparin - - prevention of thromboembolic disorders. - as part of the treatment of venous and arterial thromboembolic disorders (including early treatment of heart attacks as well as unstable angina pectoris). - for the anticoagulation in case of treatment or operation with extracorporeal circulation (e.g. heart-lung machine, hemodialysis).

HEPARIN SODIUM injection, solution Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

heparin sodium injection, solution

general injectables & vaccines, inc - heparin sodium (unii: zz45ab24ca) (heparin - unii:t2410km04a) - heparin sodium injection is indicated for: anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension; low-dose regimen for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease (see dosage and administration) prophylaxis and treatment of pulmonary embolism; atrial fibrilation with embolization; diagnosis and treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); prevention of clotting in arterial and cardiac surgery; prophylaxis and treatment of peripheral arterial embolism. heparin may also be employed as an anticoagulant in blood transfusions, extracorporeal circulation, and dialysis procedures and in blood samples for laboratory purposes. heparin sodium should not be used in patients with the following conditions: severe thrombocytopenia; when suitable blood coagulation tests, e.g.,

HEPARIN SODIUM injection solution Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

heparin sodium injection solution

cardinal health - heparin sodium (unii: zz45ab24ca) (heparin - unii:t2410km04a) - heparin 1000 [usp'u] in 1 ml

HEPARIN SODIUM injection, solution Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

heparin sodium injection, solution

fresenius kabi usa, llc - heparin sodium (unii: zz45ab24ca) (heparin - unii:t2410km04a) - heparin sodium injection is indicated for: anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension; low-dose regimen for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease (see dosage and administration ); prophylaxis and treatment of pulmonary embolism; atrial fibrillation with embolization; treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); prevention of clotting in arterial and cardiac surgery; prophylaxis and treatment of peripheral arterial embolism. heparin may also be employed as an anticoagulant in blood transfusions, extracorporeal circulation, and dialysis procedures. heparin sodium should not be used in patients with the following conditions: severe thrombocytopenia; when suitable blood coagulation tests, e.g., the whole blood clotting time, partial thro

HEPARIN SODIUM injection, solution Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

heparin sodium injection, solution

cardinal health - heparin sodium (unii: zz45ab24ca) (heparin - unii:t2410km04a) - heparin sodium injection is indicated for: anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension; low-dose regimen for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease (see dosage and administration ); prophylaxis and treatment of pulmonary embolism; atrial fibrillation with embolization; diagnosis and treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); prevention of clotting in arterial and cardiac surgery; prophylaxis and treatment of peripheral arterial embolism. heparin may also be employed as an anticoagulant in blood transfusions, extracorporeal circulation, and dialysis procedures and in blood samples for laboratory purposes. heparin sodium should not be used in patients with the following conditions: severe thrombocytopenia; when suitable blood coagulation tests, e.g